GPR183 and myeloid sarcoma: While the T cells from patients with MS and non-MS controls migrated and attached to the untreated BBB spheroids to a similar extent, inhibition of EBI2 signalling with the antagonist NIBR189, reduced the attachment to the spheroid of the T cells collected from patients with acute MS.